山西省重点保护野生植物资源及区系特征研究

以《国家重点保护野生植物名录(第一批)》和《山西省重点保护野生植物名录(第一批)》为依据,建立山西省重点保护野生植物名录。共记录57种保护植物,隶属于38科45属（其中国家Ⅰ级保护2种,国家Ⅱ级保护6种,省级保护49种）。分析结果得出,山西省重点保护野生植物在全省的分布不集中,零散分布于全省61个县区境内,且绝大多数物种的分布范围很狭窄。山西省重点保护野生植物区系具有复杂多样、起源古老、孑遗植物和单种属多等特点,科、属植物区系成分以温带分布型占优势,同时也有较明显的热带性质,过渡性特征比较明显,有其独特的地理优势和保护价值。本研究旨在对山西省重点保护野生植物资源现状及区系特征进行初步研究,从而为野生植物资源的保护和合理有效地利用提供科学的理论依据与参考。     

抗环瓜氨酸肽抗体联合类风湿因子在检测类风湿关节炎中的临床价值

目的：探讨抗环瓜氨酸肽抗体（抗CCP抗体）以及类风湿因子（RV）检测对类风湿关节炎（RA）诊断的意义。方法：采用酶联免疫吸附试验（ELISA）检测355份人血清的抗CCP抗体,同时采用使用贝克曼库尔特Image800双光镜免疫浊度分析仪定量监测类风湿因子（RF）,其中包括门诊及住院RA患者135例,非RA组170例,正常对照组来自本院的健康体检人员50例。结果：抗-CCP检测在RA组与非RA组（和正常对照组）之间的检测结果有统计学差异（P〈0．05）。RF检测在RA组与非RA组（和正常对照组）之间的检测结果有统计学差异（P〈0．05）。在135例RA病人中,抗CCP抗体的阻性率为70．4％,在非RA病人中的阳性率为3．5％,抗CCP抗体对RA的敏感性和特异性分别为70．4％、96．5％。RF的阳性率为63．7％,在非RA病人中的阳性率为14．1％,RF对RA的敏感性和特异性分别为63．7％、81．1％。联合应用抗CCP抗体与RF进行诊断,串联时敏感性为59．3％,特异性为97．1％。并联时敏感性为74．8％,特异性为85.3％。结论：抗CCP抗体和RF对RA具有较好的敏感性和很高的特异性,二者联合检测可提高对RA早期诊断的准确性。     

舒芬太尼、曲马多用于小儿鼾症手术苏醒期躁动的临床研究

目的：探究舒芬太尼与曲马多对用于小儿鼾症手术苏醒期躁动的作用与影响。方法：60例ASAI或II级扁桃体肥大或腺样体肥大的鼾症手术患儿,年龄6-14岁,无呼吸系统,循环系统等疾病,一般状态良好。随机分为舒芬太尼组（s组）和曲马多（T组）,每组各30例。常规监测各项生命体征。于手术结束前20分钟（min）,S组缓慢静脉输入0．15μg／kg舒芬太尼,T组静脉输入1．2mg／kg曲马多。观察各组的：平均动脉压 （MAP）、心率（HR）、血氧饱和度（SpO2）,进行各组的镇静评分（RSS）、躁动评分（RS）、镇痛评分（VRS）、意识状态评分（OAAS）。记录拔管前（T0）、拔管时（T1）、拔管后5min（T2）、拔管后10min（T3）、拔管后20min（T4）各时间点各参数的变化。记录各组的恶心呕吐、呼吸抑制、烦躁等的发生率。结果：SpO2各组间无显著差异。MAP,HR在各时间点的变化T组大于S组,P〈0．05,有显著差异。T组在RS,RSS,VRS评分与S组有显著差异,P〈0．05。结论：0．15μg／kg的舒芬太尼在小儿鼾症手术的苏醒期可以维持稳定的血流动力学,副作用小,镇痛效果良好,可以有效减少小儿苏醒期的躁动。     

新生儿肺炎的临床表现及x线特征的探讨

目的：探讨新生儿肺炎（neonatal pneumonia,NP）的临床表现及x线特征,以提高对NP的临床认识。方法：选择2011年6月至2012年10月在我院确诊为NP的新生儿73例,均经x线检查,回顾性分析患儿的临床资料,总结并分析患儿的临床表现及x线特征。结果：NP患儿的临床症状主要表现为呼吸急促、发绀、咳嗽、吐沫、呛奶和三凹征,部分患儿体温正常;NP的x线影像表现具有多样性,以不同程度的支气管肺炎多见,主要表现为肺纹理增多增密,局部肺野透光度降低或透光度增强。结论：NP患儿的临床症状以呼吸急促、发绀、咳嗽、吐沫、呛奶和三凹征为主,x线检查可为NP的早期诊断提供重要的临床信息,临床医师应根据NP患儿的x线影像的多样性,密切结合患儿的临床症状,做出综合分析。     

贲门失弛缓症可回收支架治疗的疗效评价

目的：观察评价可回收式支架治疗贲门失弛缓症的疗效。方法：选取来我院治疗的2003年11月～2012年7月收治的48例贲门失弛缓症患者,在DSA透视下行经口可回收食道支架置入,15-90天后将支架取出术。对术后患者治疗情况进行评价。结果：98%患者取得显著疗效。结论：可回收支架扩张治疗术具有简便、安全和疗效好等优点,并发症少,可作为贲门失弛缓症的首选治疗方法。     

Folate receptor-mediated boron-10 containing carbon nanoparticles as potential delivery vehicles for boron neutron capture therapy of nonfunctional pituitary adenomas

Invasive nonfunctional pituitary adenomas (NFPAs) are difficult to completely resect and often develop tumor recurrence after initial surgery. Currently, no medications are clinically effective in the control of NFPA. Although radiation therapy and radiosurgery are useful to prevent tumor regrowth, they are frequently withheld because of severe complications. Boron neutron capture therapy (BNCT) is a binary radiotherapy that selectively and maximally damages tumor cells without harming the surrounding normal tissue. Folate receptor (FR)-targeted boron-10 containing carbon nanoparticles is a novel boron delivery agent that can be selectively taken up by FR-expressing cells via FR-mediated endocytosis. In this study, FR-targeted boron-10 containing carbon nanoparticles were selectively taken up by NFPAs cells expressing FR but not other types of non-FR expressing pituitary adenomas. After incubation with boron-10 containing carbon nanoparticles and following irradiation with thermal neutrons, the cell viability of NFPAs was significantly decreased, while apoptotic cells were simultaneously increased. However, cells administered the same dose of FR-targeted boron-10 containing carbon nanoparticles without neutron irradiation or received the same neutron irradiation alone did not show significant decrease in cell viability or increase in apoptotic cells. The expression of Bcl-2 was down-regulated and the expression of Bax was up-regulated in NFPAs after treatment with FR-mediated BNCT. In conclusion, FR-targeted boron-10 containing carbon nanoparticles may be an ideal delivery system of boron to NFPAs cells for BNCT. Furthermore, our study also provides a novel insight into therapeutic strategies for invasive NFPA refractory to conventional therapy, while exploring these new applications of BNCT for tumors, especially benign tumors.     

Comparative analysis of intermuscular bones in fish of different ploidies

We documented the number, morphology, and distribution of intermuscular bones in five fishes of different ploidy: Carassius auratus (Abbr.WCC, 2n=100), Carassius auratus variety PengZe (Abbr.PZCC, 3n=150), improved triploid crucian carp (Abbr.ITCC, 3n=150), improved red crucian carp (Carassius auratus red var., Abbr.IRCC, ♀, 2n=100), and improved allotetraploids (Abbr.G×AT, ♂, 4n=200). The number of intermuscular bones in WCC, PZCC, and G×AT ranged from 78 to 83 ( $\bar x$ =81), 80 to 86 ( $\bar x$ =84), and 77 to 84 ( $\bar x$ =82), respectively. The numbers in ITCC and IRCC were significantly lower, ranging from 77 to 82 ( $\bar x$ =79) and 58 to 77 ( $\bar x$ =71), respectively. The average number of intermuscular bones in each sarcomere, ranked in order from highest to lowest, was 0.721 (WCC), 0.673 (PZCC), 0.653 (G×AT), 0.633 (ITCC), and 0.608 (IRCC). There was no difference between ITCC and G×AT or between G×AT and PZCC. However, the average number of intermuscular bones in the sarcomeres of ITCC, WCC, and PZCC differed significantly, as did that of IRCC and the four other kinds of fish. The intermuscular bone of these five fishes was divided into seven shape categories, non-forked (卜), one-end-unequal-bi-fork (卜), one-end-equal-bi-fork (Y), one-end-multi-fork, two-end-bi-fork, two-end-multi-fork, and tree-branch types. Generally, the morphological complexity was higher in the anterior intermuscular bones than in the posterior body. The number of intermuscular bones was similar but not equal between the left and right sides of the body. ITCC had significantly fewer intermuscular bones than either WCC or PZCC, making it of greater commercial value. Additionally, IRCC and ITCC had fewer intermuscular bones than WCC. Our observations are significant in both fish bone developmental biology and genetic breeding.